Rebel Vivienne I Insider Trades

Insider Trading History

Track insider trading activity for Rebel Vivienne I. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
BioAffinity Technologies- Warrants(23/06/2027)
BioAffinity Technologies- Warrants(23/06/2027) BIAFW
Chief Sci. & Med. Officer, EVP
Holding Value $9.25k 46,228 shares
Last Trade
Jan 31, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.28k 31,847 shares
$0.10
$0.20
BioAffinity Technologies
BioAffinity Technologies BIAF
Chief Sci. & Med. Officer, EVP
Holding Value $86.9k 46,228 shares
Last Trade
Jan 31, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$50k 31,847 shares
$1.57
$1.88
BioAffinity Technologies
BioAffinity Technologies BIAF
Evp, Chief Sci. & Med. Officer
Holding Value $27k 14,381 shares
Last Trade
Nov 17, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$19.2k 7,239 shares
$2.65
$1.88
BioAffinity Technologies- Warrants(23/06/2027)
BioAffinity Technologies- Warrants(23/06/2027) BIAFW
Evp, Chief Sci. & Med. Officer
Holding Value $2.88k 14,381 shares
Last Trade
Nov 17, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.67k 7,239 shares
$0.37
$0.20
BioAffinity Technologies
BioAffinity Technologies BIAF
Evp, Chief Sci. & Med. Officer
Holding Value $0 0 shares
Last Trade
Aug 29, 2022 Sale
No data
No data
$1.88
BioAffinity Technologies- Warrants(23/06/2027)
BioAffinity Technologies- Warrants(23/06/2027) BIAFW
Evp, Chief Sci. & Med. Officer
Holding Value $0 0 shares
Last Trade
Aug 29, 2022 Sale
No data
No data
$0.20

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up